Alterity Therapeutics to Participate in a Fireside Chat at the Cantor Global Healthcare Conference 2026 MELBOURNE, AUSTRALIA AND SAN FRANCISCO, USA – 3 September 2026: Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company...
Alterity to Present at Cantor Global Healthcare Conference
Filed with ASX · · 2 pages · English
Release
Alterity Therapeutics Ltd. on 6ix
Story so far
Earlier from Alterity Therapeutics
- Change of Director's Interest Notice - Stamler
- Change of Director's Interest Notice - Marks
- Application for quotation of securities - ATH
- Alterity Therapeutics Filed Form 20-F and XBRL Data with SEC
- $4.2M Options Underwriting Agreement Executed
Later from Alterity Therapeutics
- Alterity Therapeutics to Participate in a Fireside Chat at the Cantor Global Healthcare Conference 2026
- Cleansing Notice Under Section 708A
- Alterity Therapeutics to Present at ASX SMIDcaps Conference
- Corporate Presentation September 2026
- Date of AGM and Closing Date for Director Nominations
Follow Alterity Therapeutics into a list and get an email when it puts out news.
Follow Alterity Therapeutics